FI115442B - Matriisien valmistus - Google Patents

Matriisien valmistus Download PDF

Info

Publication number
FI115442B
FI115442B FI954883A FI954883A FI115442B FI 115442 B FI115442 B FI 115442B FI 954883 A FI954883 A FI 954883A FI 954883 A FI954883 A FI 954883A FI 115442 B FI115442 B FI 115442B
Authority
FI
Finland
Prior art keywords
cellulose
matrices
substances
process according
bioactive
Prior art date
Application number
FI954883A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954883A0 (fi
FI954883A (fi
Inventor
Gert Ragnarsson
Seth Bjoerk
Ragnar Ek
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI954883A0 publication Critical patent/FI954883A0/fi
Publication of FI954883A publication Critical patent/FI954883A/fi
Application granted granted Critical
Publication of FI115442B publication Critical patent/FI115442B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/05—Elimination by evaporation or heat degradation of a liquid phase
    • C08J2201/0504—Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Vending Machines For Individual Products (AREA)
  • Glass Compositions (AREA)
FI954883A 1993-04-14 1995-10-13 Matriisien valmistus FI115442B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE19939301220A SE9301220D0 (sv) 1993-04-14 1993-04-14 Manufacturing matrices
SE9301220 1993-04-14
SE9400331 1994-02-02
PCT/SE1994/000331 WO1994023703A1 (fr) 1993-04-14 1994-04-14 Fabrication de matrices

Publications (3)

Publication Number Publication Date
FI954883A0 FI954883A0 (fi) 1995-10-13
FI954883A FI954883A (fi) 1995-10-13
FI115442B true FI115442B (fi) 2005-05-13

Family

ID=20389559

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954883A FI115442B (fi) 1993-04-14 1995-10-13 Matriisien valmistus

Country Status (16)

Country Link
US (1) US5804217A (fr)
EP (1) EP0695173B1 (fr)
JP (1) JP3385369B2 (fr)
AT (1) ATE189120T1 (fr)
AU (1) AU680494B2 (fr)
CA (1) CA2159908C (fr)
DE (1) DE69422806T2 (fr)
DK (1) DK0695173T3 (fr)
ES (1) ES2144517T3 (fr)
FI (1) FI115442B (fr)
GR (1) GR3033274T3 (fr)
NO (1) NO312085B1 (fr)
NZ (1) NZ265131A (fr)
PT (1) PT695173E (fr)
SE (1) SE9301220D0 (fr)
WO (1) WO1994023703A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020858A1 (fr) * 1996-11-12 1998-05-22 Pharmacia & Upjohn Ab Element compact compose d'une pluralite de matrices poreuses en cellulose (pcm), son procede de fabrication et d'utilisation
US6599620B2 (en) 1997-01-07 2003-07-29 Kaneka Corporation Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification
US6416786B1 (en) 1998-12-11 2002-07-09 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6572887B2 (en) * 2000-05-01 2003-06-03 National Starch And Chemical Investment Holding Corporation Polysaccharide material for direct compression
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
TWI313278B (en) 2005-04-22 2009-08-11 Asahi Kasei Chemicals Corp Porous cellulose agglomerate and molded composition thereof
WO2009142255A1 (fr) * 2008-05-21 2009-11-26 旭化成ケミカルズ株式会社 Poudre de cellulose ayant un excellent effet de prévention de la ségrégation et compositions de celle-ci
ES2796835T3 (es) * 2013-03-13 2020-11-30 Intervet Int Bv Sustancias bioactivas estables y métodos de fabricación
JP6522396B2 (ja) * 2015-04-02 2019-05-29 北越コーポレーション株式会社 セルロース多孔質体の製造方法
AU2019101024A4 (en) * 2018-12-24 2019-10-10 Thomas W Railsback Improved cooling apparatus

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286829A (fr) * 1961-12-29
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
CS172640B1 (fr) * 1974-05-30 1977-01-28
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
SE434848B (sv) * 1976-04-22 1984-08-20 Purdue Research Foundation Forfaringssett for framstellning av porosa cellulosaperlor
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4269859A (en) * 1979-04-19 1981-05-26 Brown Company Cellulose floc granules and process
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4464224A (en) * 1982-06-30 1984-08-07 Cip Inc. Process for manufacture of high bulk paper
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JPS6443530A (en) * 1987-08-10 1989-02-15 Asahi Chemical Ind Porous cellulose particle and its production
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates
SE9002017D0 (sv) * 1990-06-06 1990-06-06 Kabivitrum Ab Process for manufacture of matrices
DE69008526T2 (de) * 1990-07-02 1994-08-18 Bend Res Inc Asymmetrische mikroporöse Kügelchen für regulierbare Freigabe.
DE59105613D1 (de) * 1990-08-24 1995-07-06 Spirig Ag Verfahren zur Herstellung von Pellets.
NZ239802A (en) * 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
US5223090A (en) * 1991-03-06 1993-06-29 The United States Of America As Represented By The Secretary Of Agriculture Method for fiber loading a chemical compound
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form

Also Published As

Publication number Publication date
AU6547394A (en) 1994-11-08
EP0695173A1 (fr) 1996-02-07
NO954079L (no) 1995-10-13
PT695173E (pt) 2000-07-31
NZ265131A (en) 1998-05-27
EP0695173B1 (fr) 2000-01-26
JPH08510766A (ja) 1996-11-12
FI954883A0 (fi) 1995-10-13
ATE189120T1 (de) 2000-02-15
ES2144517T3 (es) 2000-06-16
CA2159908A1 (fr) 1994-10-27
WO1994023703A1 (fr) 1994-10-27
US5804217A (en) 1998-09-08
AU680494B2 (en) 1997-07-31
NO312085B1 (no) 2002-03-18
GR3033274T3 (en) 2000-09-29
DK0695173T3 (da) 2000-07-10
DE69422806T2 (de) 2000-08-17
CA2159908C (fr) 2003-12-30
DE69422806D1 (de) 2000-03-02
SE9301220D0 (sv) 1993-04-14
JP3385369B2 (ja) 2003-03-10
NO954079D0 (no) 1995-10-13
FI954883A (fi) 1995-10-13

Similar Documents

Publication Publication Date Title
JP2628230B2 (ja) 微結晶性セルローススフェロニゼーション組成物
EP0609976B1 (fr) Excipient à base de cellulose microcristalline possédant une compressibilité élevée et son procédé de préparation
RU2166936C2 (ru) Способ получения дозировочных единиц путем мокрой грануляции
FI115442B (fi) Matriisien valmistus
JPH05507696A (ja) 多孔性セルロースマトリクスの製造方法
CN1149071C (zh) 含有憎水活性物质和泡腾体系的药剂及其制造方法
Sopanrao Muley et al. Formulation and optimization of lansoprazole pellets using factorial design prepared by extrusion-spheronization technique using carboxymethyl tamarind kernel powder
IE904666A1 (en) Spray drying process for making pharmaceutical powder¹compositions directly compressible into tablets
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
US6858725B1 (en) Microcrystalline cellulose cushioning granules
JP2001503766A (ja) 複数の多孔質セルロースマトリクス（ｐｃｍ）を含むコンパクト部材、その製造および使用方法
HU228638B1 (hu) Kis dózist tartalmazó tabletták és eljárás elõállításukra
CN104146977A (zh) 一种泮托拉唑钠肠溶片及其制备方法
AU681980B2 (en) Preparation of fusidic acid tablets
JPH01156913A (ja) 高薬物含量医薬組成物およびその製造法
NZ251806A (en) Making compressed tablets containing aminoguanidine or a salt thereof and a binder, by first spray-drying an aqueous solution to form a powder
US8128961B2 (en) Pharmaceutical composition, the use thereof and method for producing said composition
HUT72408A (en) Process for producing tablets containing acetyl-salicylic acid
AU775348B2 (en) Microcrystalline cellulose cushioning granules
RU2241451C1 (ru) Фармацевтическая композиция, ее применение и способ получения
EP1338275A1 (fr) Composition pharmaceutique, son application et procede de fabrication
PL205139B1 (pl) Sposób ulepszania własności powierzchniowych tabletek farmaceutycznych
GB2350582A (en) A method of tableting
US20050113444A1 (en) Method of producing a tocopherol product
EA003863B1 (ru) Фармацевтическая композиция, ее применение и способ получения

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115442

Country of ref document: FI

MA Patent expired